Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Innocan Pharma Corp
(OP:
INNPF
)
4.660
-0.570 (-10.90%)
Streaming Delayed Price
Updated: 11:40 AM EST, Feb 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,050
Open
5.000
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
5.230
Today's Range
4.660 - 5.000
52wk Range
0.0800 - 14.26
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
↗
April 04, 2025
This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.
Via
Benzinga
Topics
Government
Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth
↗
November 21, 2024
Innocan Pharma reports 174% YoY revenue growth in Q3 2024, driven by innovation in cannabinoids and strong sales from BI Sky Global Ltd.
Via
Benzinga
Performance
YTD
-21.3%
-21.3%
1 Month
-19.1%
-19.1%
3 Month
-49.3%
-49.3%
6 Month
+2906.5%
+2906.5%
1 Year
+3977.0%
+3977.0%
More News
Read More
CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
↗
May 28, 2024
Via
Benzinga
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
↗
April 23, 2024
Via
Benzinga
534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
↗
April 02, 2024
Via
Benzinga
CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
↗
February 13, 2024
Via
Benzinga
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
↗
December 22, 2023
Via
Benzinga
Topics
Cannabis
More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It
↗
October 23, 2023
Via
Benzinga
Topics
Cannabis
CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare
↗
September 21, 2023
Via
Benzinga
Innocan Pharma's Q2 2023 Reports Gross Profit Growth Driven By Robust Subsidiary Sales
↗
August 28, 2023
Via
Benzinga
Innocan Pharma Secures $1.4M Via Private Placement
↗
August 04, 2023
Via
Benzinga
Innocan Pharma To Secure Up To $3M Via Private Placement Of Units At A 9% Prime Above Share Price
↗
July 25, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 25, 2023
↗
August 25, 2023
Via
Benzinga
Topics
Cannabis
Cannabis Stock Movers For July 21, 2023
↗
July 21, 2023
Via
Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
↗
August 21, 2023
Via
Benzinga
Topics
Cannabis
Innocan Pharma Q1 Revenue Grows 500%, Here Is What You Need To Know
↗
June 01, 2023
Via
Benzinga
Innocan Pharma FY22 Revenue Grows 1205% To $2.6M, Here Is What You Need To Know
↗
April 19, 2023
Via
Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
↗
August 17, 2023
Via
Benzinga
Topics
Cannabis
Can Liposomal CBD Injection Help Dogs With Polyarthritis? Innocan Pharma Reports Clinical Success
↗
February 21, 2023
Via
Benzinga
Innocan Pharma Q3 Revenue Grows 700% YoY, Here Is What You Need To Know
↗
November 29, 2022
Via
Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
↗
August 14, 2023
Via
Benzinga
Topics
Cannabis
Innocan Pharma Provides an Operational Update
September 21, 2022
Via
Newsfile
Topics
Intellectual Property
Cannabis Stock Gainers And Losers From August 11, 2023
↗
August 11, 2023
Via
Benzinga
Topics
Cannabis
Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment
September 09, 2022
Via
Newsfile
Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
September 06, 2022
Via
Newsfile
Frequently Asked Questions
Is Innocan Pharma Corp publicly traded?
Yes, Innocan Pharma Corp is publicly traded.
What exchange does Innocan Pharma Corp trade on?
Innocan Pharma Corp trades on the OTC Traded
What is the ticker symbol for Innocan Pharma Corp?
The ticker symbol for Innocan Pharma Corp is INNPF on the OTC Traded
What is the current price of Innocan Pharma Corp?
The current price of Innocan Pharma Corp is 4.660
When was Innocan Pharma Corp last traded?
The last trade of Innocan Pharma Corp was at 02/06/26 11:40 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today